We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+9.79%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$15.7B
AUM Growth
+$2.32B
(+17%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
8.02%
Top 10 Holdings %
Top 10 Hldgs %
18.6%
Holding
1,228
New
419
Increased
306
Reduced
272
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$224M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$202M |
| 3 |
Vodafone
VOD
|
+$185M |
| 4 |
General Motors
GM
|
+$183M |
| 5 |
Infosys
INFY
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$238M |
| 2 |
TSMC
TSM
|
+$157M |
| 3 |
AstraZeneca
AZN
|
+$151M |
| 4 |
Netflix
NFLX
|
+$148M |
| 5 |
Intel
INTC
|
+$99.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 17.62% |
| 3 | Communication Services | 12.58% |
| 4 | Consumer Staples | 9.85% |
| 5 | Financials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTS
801
DELISTED
Triple-S Management Corporation
GTS
| $464K | ﹤0.01% |
26,548
+12,565
| +90% | +$242K |
|
|
SEM
802
DELISTED
Select Medical
SEM
| $459K | ﹤0.01% |
105,467
-15,980
| -13% | -$73K |
|
803
Trane Technologies
TT
$106B
| $459K | ﹤0.01% |
+8,857
| New | +$434K |
|
|
FNSR
804
DELISTED
Finisar Corp
FNSR
| $456K | ﹤0.01% |
20,133
-134,470
| -87% | -$2.77M |
|
805
Bio-Rad Laboratories Class A
BIO
$9.42B
| $451K | ﹤0.01% |
3,840
-15,231
| -80% | -$1.8M |
|
|
SRGA
806
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $450K | ﹤0.01% |
4,013
| – | – |
|
807
Evertec
EVTC
$1.78B
| $448K | ﹤0.01% |
+20,168
| New | +$480K |
|
808
AGCO
AGCO
$7.2B
| $443K | ﹤0.01% |
+7,327
| New | +$415K |
|
|
NIHD
809
DELISTED
NII HOLDINGS INC CL B
NIHD
| $433K | ﹤0.01% |
+71,327
| New | +$481K |
|
|
PCP
810
DELISTED
PRECISION CASTPARTS CORP
PCP
| $432K | ﹤0.01% |
+1,900
| New | +$429K |
|
|
MCGC
811
DELISTED
MCG CAP CORP
MCGC
| $432K | ﹤0.01% |
+85,713
| New | +$442K |
|
|
TESO
812
DELISTED
Tesco Corp
TESO
| $431K | ﹤0.01% |
+25,996
| New | +$388K |
|
|
PGTI
813
DELISTED
PGT, Inc.
PGTI
| $428K | ﹤0.01% |
+43,151
| New | +$435K |
|
814
Greif
GEF
$5.04B
| $426K | ﹤0.01% |
+8,698
| New | +$468K |
|
815
AMN Healthcare
AMN
$1.4B
| $422K | ﹤0.01% |
+30,703
| New | +$451K |
|
816
Reliance Steel & Aluminium
RS
$21.6B
| $422K | ﹤0.01% |
+5,755
| New | +$402K |
|
817
JetBlue
JBLU
$2.29B
| $408K | ﹤0.01% |
+61,272
| New | +$396K |
|
|
FDML
818
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $407K | ﹤0.01% |
+24,255
| New | +$363K |
|
819
W.W. Grainger
GWW
$60.2B
| $404K | ﹤0.01% |
+1,542
| New | +$401K |
|
|
BXE
820
DELISTED
Bellatrix Exploration Ltd.
BXE
| $399K | ﹤0.01% |
+10,472
| New | +$357K |
|
821
Armstrong World Industries
AWI
$7.84B
| $392K | ﹤0.01% |
+7,127
| New | +$360K |
|
822
Iridium Communications
IRDM
$5.29B
| $391K | ﹤0.01% |
+56,780
| New | +$425K |
|
|
SMRT
823
DELISTED
Stein Mart Inc
SMRT
| $390K | ﹤0.01% |
28,418
+3,071
| +12% | +$41.3K |
|
|
VOCS
824
DELISTED
VOCUS INC
VOCS
| $383K | ﹤0.01% |
41,163
-19,929
| -33% | -$202K |
|
825
DexCom
DXCM
$32B
| $382K | ﹤0.01% |
+54,080
| New | +$343K |
|
Similar funds
VGA
Arrowstreet Capital's Q3 2013 Portfolio in Review
As of Q3 2013, Arrowstreet Capital held 1,228 positions worth $15.7B, up 17% from $13.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital deployed $1.26B of net new capital in Q3 2013, opening 419 new positions and adding to 306 existing holdings. Its largest new stake was Ericsson: 5,508,729 shares worth $73.5M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 24% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was GSK, an estimated $238M trimmed.
- Arrowstreet Capital's largest Q3 2013 buy was Ericsson: 5,508,729 shares worth $73.5M.
- Arrowstreet Capital added most to Cisco in Q3 2013, an estimated $224M increase.
- Arrowstreet Capital's biggest Q3 2013 reduction was GSK, cutting an estimated $238M.
- Arrowstreet Capital fully exited TSMC in Q3 2013, selling an estimated $157M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $15.7B portfolio in Q3 2013.
- Arrowstreet Capital opened 419 new positions and closed 217 in Q3 2013.
- Arrowstreet Capital's portfolio value rose 17% quarter-over-quarter to $15.7B.
Based on Arrowstreet Capital's 13F filing for Q3 2013, filed 14 Nov 2013.